Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Cholestyramine Oral Suspension USP
Company:  Baker Norton Pharmaceuticals, Inc.
Application No.:  74-771
Approval Date: 7/9/1997


Date created: January 18, 2006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.